A detailed history of Hoey Investments, Inc transactions in Organon & Co. stock. As of the latest transaction made, Hoey Investments, Inc holds 191 shares of OGN stock, worth $2,971. This represents 0.0% of its overall portfolio holdings.

Number of Shares
191
Previous 191 -0.0%
Holding current value
$2,971
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$17.45 - $21.96 $209 - $263
-12 Reduced 5.91%
191 $3,000
Q1 2024

May 09, 2024

SELL
$13.78 - $18.8 $124 - $169
-9 Reduced 4.25%
203 $3,000
Q4 2023

Feb 12, 2024

SELL
$10.95 - $17.32 $21 - $34
-2 Reduced 0.93%
212 $3,000
Q3 2023

Apr 22, 2024

SELL
$16.59 - $23.77 $116 - $166
-7 Reduced 3.17%
214 $3,000
Q3 2023

Oct 23, 2023

SELL
$16.59 - $23.77 $116 - $166
-7 Reduced 3.17%
214 $3,000
Q2 2023

Apr 22, 2024

BUY
$19.27 - $24.63 $924 - $1,182
48 Added 27.75%
221 $4,000
Q2 2023

Aug 11, 2023

BUY
$19.27 - $24.63 $924 - $1,182
48 Added 27.75%
221 $4,000
Q1 2023

Apr 22, 2024

SELL
$21.42 - $32.08 $835 - $1,251
-39 Reduced 18.4%
173 $4,000
Q1 2023

May 11, 2023

SELL
$21.42 - $32.08 $42 - $64
-2 Reduced 1.14%
173 $4,000
Q4 2022

Feb 13, 2023

SELL
$23.31 - $28.61 $512 - $629
-22 Reduced 11.17%
175 $4,000
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $4,843 - $7,089
-207 Reduced 51.24%
197 $5,000
Q2 2022

Aug 11, 2022

SELL
$31.66 - $38.9 $2,437 - $2,995
-77 Reduced 16.01%
404 $14,000
Q1 2022

Apr 25, 2022

SELL
$30.45 - $39.36 $365 - $472
-12 Reduced 2.43%
481 $17,000
Q4 2021

Feb 14, 2022

SELL
$28.67 - $37.13 $57 - $74
-2 Reduced 0.4%
493 $15,000
Q3 2021

Nov 12, 2021

SELL
$28.63 - $35.64 $1,603 - $1,995
-56 Reduced 10.16%
495 $16,000
Q2 2021

Nov 12, 2021

BUY
$28.45 - $38.0 $15,675 - $20,938
551 New
551 $17,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.96B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Hoey Investments, Inc Portfolio

Follow Hoey Investments, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoey Investments, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hoey Investments, Inc with notifications on news.